Gene Therapies for Inherited Retinal Diseases
Presenters
Eric A. Pierce, MD, PhD; Rachel M. Huckfeldt, MD, PhD and Brian Ballios, MD, PhD,
Description
ARVO and the American Academy of Ophthalmology (AAO) partnered to deliver this webinar focused on genetic therapies for inherited retinal disorders. Listen as our panel of experts share stories and discuss the history of gene therapy, its current uses and future potential. Dr. Pierce provides a historical account of gene therapy uses for inherited retinal diseases, while Dr. Huckfeldt discusses current uses, FDA approval, clinical trials, additional promising therapies, technologies and gene editing. Dr. Balios addresses where we are heading in the future of gene therapies.
Estimated Duration
1 hour
Members-in-Training ($0); Members ($0)
Description
Organizers
This webinar is part of an annual collaboration between ARVO’s Professional Development and Education Committee and the AAO Committee for Resident Education to develop research-related education for medical students, residents and ARVO Members-in-Training.
Attendees will leave this session with the ability to:
- Explain the history of gene therapies for inherited retinal diseases
- Articulate the FDA approval process and clinical trials for gene therapies
- Identify new technologies in gene editing and promising future therapies for inherited retinal diseases